Symbol Lookup

Wednesday June 19, 2013 5:56 AM ET. Data delayed 15 minutes.
34.41
0.00 (0.00%)
Bid/Lots
32.16/2
Ask/Lots
0.00/0
Open/Prev Close
0.00/34.41
Day Range
-----
52-Week Range
23.73-35.86
Vol/Avg Daily Vol
0.0/1.3M
Price Comparison Chart
Data delayed at least 15 minutes.

Recent News»

0 New Today
BioForward Continues Wisconsin Outreach
18 hours ago by Business Wire

Wisconsin biotech advocacy organization, BioForward, has announced that its 2013 Bioscience Vision Summit, scheduled for September 18, 2013 at the Monona Terrace Convention Center will feature three prominent industry profe...

PerkinElmer Board Declares Quarterly Dividend
4:05PM ET on Thursday Jun 13, 2013 by Business Wire

The Board of Directors of PerkinElmer, Inc. (NYSE: PKI), declared a regular quarterly dividend of $0.07 per share of common stock on June 13, 2013. This dividend is payable on August 9, 2013, to all shareholders of record a...

PerkinElmer Introduces New Generation of Tandem Mass Spectrometer
9:03AM ET on Monday Jun 10, 2013 by Business Wire

At the 2013 American Society for Mass Spectrometry Conference, PerkinElmer Inc., a global leader focused on the health and safety of people and the environment, introduced the AxION iQT gas chromatography tandem mass...

Biotech Services Take Advantage of Technological Revolution through Innovations - Research Report on Life Technologies, PerkinElmer, PAREXEL, Genomic Health, and Bio-Reference
8:00AM ET on Friday Jun 07, 2013 by PR Newswire

Editor Note: For more information about this release, please scroll to bottom.

Today, Wall Street Reports announced new research reports highlighting Life Technologies Corporation (NASDAQ: LIFE), PerkinElmer, Inc. (NYSE: PKI), PAREXEL In...

PerkinElmer to Present at Goldman Sachs Global Healthcare Conference
4:05PM ET on Tuesday Jun 04, 2013 by Business Wire

PerkinElmer, Inc. (NYSE: PKI), a global leader focused on improving the health and safety of people and the environment, today announced that the Company will present at the Goldman Sachs Global Healthcare Conference ...

Company Information

PerkinElmer, Inc. is a provider of technology, services and solutions to the diagnostics, research, environmental, industrial and laboratory services markets. Through the Company's advanced technologies, solutions, and services, it addresses issues related to health and safety of people and their environment. It operates in two segments: Human Health and Environmental Health. In February 2011, it acquired chemagen Biopolymer-Technologie AG (chemagen). In March 2011, it acquired ArtusLabs, Inc. (ArtusLabs). In March 2011, it acquired specified assets and assumed specified liabilities of ID Biological Systems, Inc. (IDB). In April 2011, it acquired CambridgeSoft Corporation (CambridgeSoft). In May 2011, it acquired Geospiza, Inc. (Geospiza). In May 2011, it acquired Labtronics, Inc. (Labtronics). In June 2011, it acquired Dexela Limited (Dexela). In November 2011, it acquired Caliper Life Sciences, Inc. (Caliper).

CONTACT INFORMATION

Headquarters940 Winter Street
WALTHAM, MA, United States 02451
Phone781-663-6900
Fax781-663-5985

EXECUTIVE OFFICERS

Chairman of the Board, President, Chief Executive OfficerRobert Friel
Chief Financial Officer, Senior Vice PresidentFrank Wilson
Chief Scientific Officer, Senior Vice President, President - Emerging DiagnosticsDaniel Marshak
Senior Vice President, General Counsel, SecretaryJoel Goldberg
Senior Vice President - Human ResourcesJohn Letcher

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

Stocks Ratings Sample

With TD Waterhouse, you have access to the industry's leading selection of independent research reports from providers such as TDSI, TD Securities, S&P, INK and Argus.

Open a New Account, or Login if you're a client.

  •  
  • INK Company Insider

    Detailed daily analysis of insider activity and holdings for stocks and income trusts listed in Canada, based on filings from SEDI®

  • Standard & Poor's Stock Report

    Standard & Poor's analysts' overview and valuation, with key fundamental, quantitative, and technical analysis.

  • TDSI Morning Action Notes

    Morning Institutional Report of company updates and new recommendations.

Market Cap$3.9BBeta1.00
Revenue (TTM)$2.1BEPS$0.69
Shares Out.111.9MBook Value$16.86
Dividend Yield0.81%P/E50.1x
Annual Dividend Rate$0.28Price/Sales (TTM)1.8
Ex-Div Date4/17/13P/Cash Flow (TTM)13.1x
Pay Date8/9/13Operating Margin4.65%

*GAAP = prior to non-GAAP analyst adjusted earnings.

(Non-GAAP)*

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.

Stocks Calendar Sample